Daniel A. Camardo - Net Worth and Insider Trading
Daniel A. Camardo Net Worth
The estimated net worth of Daniel A. Camardo is at least $4 Million dollars as of 2024-11-29. Daniel A. Camardo is the EVP and President, U.S. of Horizon Therapeutics PLC and owns about 32,900 shares of Horizon Therapeutics PLC (HZNP) stock worth over $4 Million. Daniel A. Camardo is also the CEO of Athersys Inc and owns about 368,804 shares of Athersys Inc (ATHXQ) stock worth over $37. Details can be seen in Daniel A. Camardo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel A. Camardo has not made any transactions after 2022-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel A. Camardo
Daniel A. Camardo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel A. Camardo owns 2 companies in total, including Horizon Therapeutics PLC (HZNP) , and Athersys Inc (ATHXQ) .
Click here to see the complete history of Daniel A. Camardo’s form 4 insider trades.
Insider Ownership Summary of Daniel A. Camardo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2021-03-30 | EVP and President & U.S. |
| ATHXQ | Athersys Inc | 2022-11-22 | director & Chief Executive Officer |
Daniel A. Camardo Latest Holdings Summary
Daniel A. Camardo currently owns a total of 2 stocks. Among these stocks, Daniel A. Camardo owns 32,900 shares of Horizon Therapeutics PLC (HZNP) as of March 30, 2021, with a value of $4 Million and a weighting of 100%. Daniel A. Camardo also owns 368,804 shares of Athersys Inc (ATHXQ) as of November 22, 2022, with a value of $37 and a weighting of 0%.
Latest Holdings of Daniel A. Camardo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2021-03-30 | 32,900 | 116.30 | 3,826,270 |
| ATHXQ | Athersys Inc | 2022-11-22 | 368,804 | 0.00 | 37 |
Holding Weightings of Daniel A. Camardo
Daniel A. Camardo Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel A. Camardo has made a total of 2 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Horizon Therapeutics PLC is the sale of 12,900 shares on March 30, 2021, which brought Daniel A. Camardo around $1 Million.
According to the SEC Form 4 filings, Daniel A. Camardo has made a total of 2 transactions in Athersys Inc (ATHXQ) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Athersys Inc is the acquisition of 100,000 shares on November 22, 2022, which cost Daniel A. Camardo around $55,000.
Insider Trading History of Daniel A. Camardo
- 1
Daniel A. Camardo Trading Performance
GuruFocus tracks the stock performance after each of Daniel A. Camardo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel A. Camardo is 63.2%. GuruFocus also compares Daniel A. Camardo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel A. Camardo within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel A. Camardo's insider trading performs compared to the benchmark.
Performance of Daniel A. Camardo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.34 | | | | | |
| Relative Return to S&P 500(%) | 10.82 | | | | | |
Daniel A. Camardo Ownership Network
Daniel A. Camardo Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Daniel A. Camardo is the EVP and President & U.S. of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Daniel A. Camardo Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel A. Camardo. You might contact Daniel A. Camardo via mailing address: Athersys, Inc., 3201 Carnegie Ave, Cleveland Oh 44115.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
